1984
DOI: 10.1016/s0021-9673(01)96174-6
|View full text |Cite
|
Sign up to set email alerts
|

Isotachophoretic analysis of a synthetic dipeptide l-alanyl-l-glutamine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

1987
1987
2020
2020

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(9 citation statements)
references
References 14 publications
0
9
0
Order By: Relevance
“…(159) as con firmed for specific dipeptides containing glutamine (C-terminal), tyrosine, and cysteine, which are resistant to heat sterilization (186). Quality control tech niques such as high-performance liquid chromatography (HPLC), isotacho phoresis, nuclear magnetic resonance (NMR), and mass spectrometry (MS) have been applied to ensure purity (186,191). Protein hydrolysate toxicity and composition as well as peptide-chain length profile and composition have been determined by standard in vitro/in vivo testing (112, 206), amino acid analysis, Cu(lI)-sephadex chromatography ( …”
Section: General Considerations For Use Of Parenteral Peptidesmentioning
confidence: 99%
See 1 more Smart Citation
“…(159) as con firmed for specific dipeptides containing glutamine (C-terminal), tyrosine, and cysteine, which are resistant to heat sterilization (186). Quality control tech niques such as high-performance liquid chromatography (HPLC), isotacho phoresis, nuclear magnetic resonance (NMR), and mass spectrometry (MS) have been applied to ensure purity (186,191). Protein hydrolysate toxicity and composition as well as peptide-chain length profile and composition have been determined by standard in vitro/in vivo testing (112, 206), amino acid analysis, Cu(lI)-sephadex chromatography ( …”
Section: General Considerations For Use Of Parenteral Peptidesmentioning
confidence: 99%
“…amounts cannot be given to fluid-restricted patients. Although hospital manufacturing pharmacies may formulate L-glutamine solutions sub ject to normal pharmaceutical safeguards (74), commercial solutions of termi nally sterilized, glutamine dipeptide-supplemented amino acids solutions with good long-term stability will eventually be made available (191).…”
Section: Glutamine Peptide Prodrugsmentioning
confidence: 99%
“…The intestine utilizes glutamine for the maintenance of the barrier function and in the regulation of the inflammation and apoptosis (Carneiro et al, 2006;Li and Neu, 2009;Hou et al, 2013). Glutamine is very poorly soluble and unstable during storage and heat sterilization, which limits its addition in the existing preparations (Stehle et al, 1984). However, these shortcomings can be overcome by employing a synthetic dipeptide containing glutamine, L-alanyl-L-glutamine (Ala-Gln) (Furst et al, 1987;Furst et al, 1990).…”
Section: Introductionmentioning
confidence: 99%
“…l -Alanyl- l -glutamine (Ala-Gln) and glycyl- l -glutamine (Gly-Gln) are supposed to be two main types of glutamine-containing dipeptides in clinical practice [9]. Ala-Gln has been clinically selected as the most suitable alternative of Gln because of its high thermostability under heat sterilization, highly solubility (568 g/L), and higher decomposition rate [10, 11]. Beyond that, Ala-Gln will be rapidly removed from plasma after parenteral administration without accumulation in tissues and undetectable in urine [12].…”
Section: Introductionmentioning
confidence: 99%